Literature DB >> 3587918

Retinoblastoma with anterior chamber extension.

B G Haik, S A Dunleavy, C Cooke, R M Ellsworth, D H Abramson, M E Smith, Z A Karcioglu.   

Abstract

Anterior chamber retinoblastoma is a rare clinical entity. The authors have reviewed the records of 1500 patients with retinoblastoma to determine the incidence and prognostic ramifications. Of 30 patients with anterior chamber involvement, 15 were noted on initial examination and 15 during observation after therapy. Despite aggressive multimodality treatment, total response was never achieved and all eyes were eventually lost. Results of pathologic examination showed ciliary body invasion, which was held accountable for the poor response to therapy. Anterior chamber retinoblastoma is a poor prognostic sign which cannot be controlled effectively with current techniques and should be considered an indication for enucleation without delay.

Entities:  

Mesh:

Year:  1987        PMID: 3587918     DOI: 10.1016/s0161-6420(87)33437-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  Massive anterior chamber involvement after intra-arterial chemotherapy for retinoblastoma: ultrasound biomicroscopy and histopathology.

Authors:  Sonia De Francesco; Francesco Pichi; Andrea Lembo; Domenico Mastrangelo; Anna Paradiso; Mariacarla De Luca; Paolo Toti; Paolo Nucci; Theodora Hadjistilianou
Journal:  Int Ophthalmol       Date:  2014-01-30       Impact factor: 2.031

2.  Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.

Authors:  Patricia Chévez-Barrios; Ralph C Eagle; Mark Krailo; Jin Piao; Daniel M Albert; Yun Gao; Geeta Vemuganti; Mohammad Javed Ali; Vikas Khetan; Santosh G Honavar; Joan O'Brien; Ann-Marie Leahey; Katherine Matthay; Anna Meadows; Murali Chintagumpala
Journal:  J Clin Oncol       Date:  2019-09-20       Impact factor: 44.544

3.  Histopathologic grading of anaplasia in retinoblastoma.

Authors:  Pia R Mendoza; Charles S Specht; G Baker Hubbard; Jill R Wells; Michael J Lynn; Qing Zhang; Jun Kong; Hans E Grossniklaus
Journal:  Am J Ophthalmol       Date:  2014-12-19       Impact factor: 5.258

4.  Clinical presentation of retinoblastoma in Malaysia: a review of 64 patients.

Authors:  S C Reddy; S Anusya
Journal:  Int J Ophthalmol       Date:  2010-03-18       Impact factor: 1.779

5.  Distinct Gene Expression Profiles Define Anaplastic Grade in Retinoblastoma.

Authors:  Lauren E Hudson; Pia Mendoza; William H Hudson; Alison Ziesel; G Baker Hubbard; Jill Wells; Bhakti Dwivedi; Jeanne Kowalski; Sandra Seby; Viren Patel; Eldon Geisert; Charles Specht; Hans E Grossniklaus
Journal:  Am J Pathol       Date:  2018-07-21       Impact factor: 4.307

6.  Intracameral Chemotherapy (Melphalan) for Aqueous Seeding in Retinoblastoma: Bicameral Injection Technique and Related Toxicity in a Pilot Case Study.

Authors:  Francis L Munier; Marie-Claire Gaillard; Sarah Decembrini; Massimo Bongiovanni; Maja Beck-Popovic
Journal:  Ocul Oncol Pathol       Date:  2016-12-29

7.  Retinoblastoma associated orbital cellulitis.

Authors:  P B Mullaney; Z A Karcioglu; A M Huaman; S al-Mesfer
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

8.  Clinical Characteristics and Image Manifestations of a Rare Retinoblastoma with a Bone Metastasis.

Authors:  Huali Gu; Yizhuo Wang; Dongsheng Huang; Xunda Ji; Yi Zhang; Jianmin Ma; Mei Li; Weiling Zhang; Huimin Hu; Jing Li; Pinwei Zhang
Journal:  Cancer Manag Res       Date:  2022-04-26       Impact factor: 3.602

9.  Retinoblastoma presenting as pseudohypopyon and preserved visual acuity.

Authors:  Andrea L Blitzer; Sidney A Schechet; Hassan A Shah; Michael P Blair
Journal:  Am J Ophthalmol Case Rep       Date:  2021-06-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.